{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:01:55Z","timestamp":1794405715189,"version":"4.9.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016286","name":"Urmia University of Medical Sciences","doi-asserted-by":"publisher","award":["Urmia University of Medical Sciences"],"award-info":[{"award-number":["Urmia University of Medical Sciences"]}],"id":[{"id":"10.13039\/501100016286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12010-026-05865-w","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:29:55Z","timestamp":1785810595000},"page":"8165-8193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neural Stem Cells in Multiple Sclerosis: A Comprehensive Review of Preclinical and Clinical Evidence for CNS Repair and Translational Hurdles"],"prefix":"10.1007","volume":"198","author":[{"given":"Elham","family":"Razzaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezo","family":"Azari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-5046","authenticated-orcid":false,"given":"Ali","family":"Golchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynaz","family":"Mihanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"8","key":"5865_CR1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt, G., Thompson, A., Berg, J., Gannedahl, M., Eriksson, J., Group MS. (2017). New insights into the burden and costs of multiple sclerosis in Europe. Multiple Sclerosis Journal, 23(8), 1123\u201336.","journal-title":"Multiple Sclerosis Journal"},{"issue":"11","key":"5865_CR2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","volume":"83","author":"P Browne","year":"2014","unstructured":"Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., et al. (2014). Atlas of multiple sclerosis 2013: A growing global problem with widespread inequity. Neurology, 83(11), 1022\u20131024.","journal-title":"Neurology"},{"issue":"7","key":"5865_CR3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","volume":"9","author":"SV Ramagopalan","year":"2010","unstructured":"Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G. (2010). Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. The Lancet Neurology, 9(7), 727\u201339.","journal-title":"The Lancet Neurology"},{"issue":"4","key":"5865_CR4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin, F. D., Reingold, S. C., & Sclerosis*, N. M. S. S. A. C. C. T. N. A. M. (1996). Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology, 46(4), 907\u2013911.","journal-title":"Neurology"},{"issue":"5","key":"5865_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.apjtb.2017.02.001","volume":"7","author":"KMM Koriem","year":"2017","unstructured":"Koriem, K. M. M. (2017). Corrigendum to \u2018Multiple sclerosis: New insights and trends\u2019. Asian Pacific Journal of Tropical Biomedicine, 7(5), 493\u2013504.","journal-title":"Asian Pacific Journal of Tropical Biomedicine"},{"key":"5865_CR6","doi-asserted-by":"crossref","first-page":"iii3","DOI":"10.1007\/s00415-005-2010-6","volume":"252","author":"F Lublin","year":"2005","unstructured":"Lublin, F. (2005). History of modern multiple sclerosis therapy. Journal of Neurology, 252, iii3\u2013iii9.","journal-title":"Journal of Neurology"},{"issue":"6","key":"5865_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1756285617708911","volume":"10","author":"UW Kaunzner","year":"2017","unstructured":"Kaunzner, U. W., & Gauthier, S. A. (2017). MRI in the assessment and monitoring of multiple sclerosis: An update on best practice. Therapeutic Advances in Neurological Disorders, 10(6), 247\u201361.","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"6","key":"5865_CR8","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.696","volume":"7","author":"C Madsen","year":"2017","unstructured":"Madsen, C. (2017). The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis. Brain and Behavior, 7(6), Article e00696.","journal-title":"Brain and Behavior"},{"issue":"3","key":"5865_CR9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrneurol.2015.14","volume":"11","author":"RM Ransohoff","year":"2015","unstructured":"Ransohoff, R. M., Hafler, D. A., & Lucchinetti, C. F. (2015). Multiple sclerosis\u2014A quiet revolution. Nature Reviews Neurology, 11(3), 134\u201342.","journal-title":"Nature Reviews Neurology"},{"issue":"1","key":"5865_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13311-012-0160-7","volume":"10","author":"R Berkovich","year":"2013","unstructured":"Berkovich, R. (2013). Treatment of Acute Relapses in Multiple Sclerosis. Neurotherapeutics, 10(1), 97\u2013105.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"5865_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jpm12010006","volume":"12","author":"C Ramo-Tello","year":"2021","unstructured":"Ramo-Tello, C., Blanco, Y., Brieva, L., Casanova, B., Mart\u00ednez-C\u00e1ceres, E., Ontaneda, D., et al. (2021). Recommendations for the diagnosis and treatment of multiple sclerosis relapses. Journal of Personalized Medicine, 12(1), 6.","journal-title":"Journal of Personalized Medicine"},{"issue":"3","key":"5865_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3988\/jcn.2022.0208","volume":"19","author":"AB Baskaran","year":"2023","unstructured":"Baskaran, A. B., Grebenciucova, E., Shoemaker, T., & Graham, E. L. (2023). Current updates on the diagnosis and management of multiple sclerosis for the general neurologist. Journal of Clinical Neurology, 19(3), 217.","journal-title":"Journal of Clinical Neurology"},{"issue":"1","key":"5865_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/13524585211008760","volume":"28","author":"JR Allanach","year":"2022","unstructured":"Allanach, J. R., Farrell, J. W., M\u00e9sidor, M., & Karimi-Abdolrezaee, S. (2022). Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: A systematic review. Multiple Sclerosis Journal, 28(1), 29\u201348.","journal-title":"Multiple Sclerosis Journal"},{"issue":"4","key":"5865_CR14","first-page":"95","volume":"11","author":"AR Zadeh","year":"2019","unstructured":"Zadeh, A. R., Askari, M., Azadani, N. N., Ataei, A., Ghadimi, K., Tavoosi, N., et al. (2019). Mechanism and adverse effects of multiple sclerosis drugs: A review article. Part 1. International journal of physiology pathophysiology and pharmacology, 11(4), 95.","journal-title":"International journal of physiology pathophysiology and pharmacology"},{"issue":"6","key":"5865_CR15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2217\/cer-2020-0267","volume":"10","author":"IA Samjoo","year":"2021","unstructured":"Samjoo, I. A., Worthington, E., Drudge, C., Zhao, M., Cameron, C., H\u00e4ring, D. A., et al. (2021). Efficacy classification of modern therapies in multiple sclerosis. Journal of Comparative Effectiveness Research, 10(6), 495\u2013507.","journal-title":"Journal of Comparative Effectiveness Research"},{"issue":"3","key":"5865_CR16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10561-022-10062-0","volume":"24","author":"SS Ashraf","year":"2023","unstructured":"Ashraf, S. S., Hosseinpour Sarmadi, V., Larijani, G., Naderi Garahgheshlagh, S., Ramezani, S., Moghadamifar, S., et al. (2023). Regenerative medicine improve neurodegenerative diseases. Cell and Tissue Banking, 24(3), 639\u2013650.","journal-title":"Cell and Tissue Banking"},{"key":"5865_CR17","doi-asserted-by":"publisher","unstructured":"Golchin, A., Rahnama, M., Chapani, M. S., Shams, F., Rekabgardan, M., Poursalehi, Z., et al. (2025). Tissue engineering in cosmetics and dermatology: A new era of innovation and application. The Open Dermatology Journal, 19, e18743722398355. https:\/\/doi.org\/10.2174\/0118743722398355250709053244","DOI":"10.2174\/0118743722398355250709053244"},{"key":"5865_CR18","doi-asserted-by":"publisher","first-page":"102875","DOI":"10.1016\/j.tice.2025.102875","volume":"95","author":"ME Abbaszadeh","year":"2025","unstructured":"Abbaszadeh, M. E., Esmaeili, M., Bilabari, M., & Golchin, A. (2025). Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review. Tissue & Cell, 95, 102875. https:\/\/doi.org\/10.1016\/j.tice.2025.102875","journal-title":"Tissue & Cell"},{"issue":"47","key":"5865_CR19","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1073\/pnas.1508520112","volume":"112","author":"AS Mao","year":"2015","unstructured":"Mao, A. S., & Mooney, D. J. (2015). Regenerative medicine: Current therapies and future directions. Proceedings of the National Academy of Sciences of the United States of America, 112(47), 14452\u20139.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"5865_CR20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/bmb\/lds024","volume":"104","author":"G Gincberg","year":"2012","unstructured":"Gincberg, G., Arien-Zakay, H., Lazarovici, P., & Lelkes, P. I. (2012). Neural stem cells: Therapeutic potential for neurodegenerative diseases. British Medical Bulletin, 104(1), 7\u201319.","journal-title":"British Medical Bulletin"},{"issue":"5457","key":"5865_CR21","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","volume":"287","author":"FH Gage","year":"2000","unstructured":"Gage, F. H. (2000). Mammalian neural stem cells. Science, 287(5457), 1433\u20131438.","journal-title":"Science"},{"issue":"8","key":"5865_CR22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/stcltm\/szad041","volume":"12","author":"Y Fan","year":"2023","unstructured":"Fan, Y., Goh, E. L., & Chan, J. K. Y. (2023). Neural cells for neurodegenerative diseases in clinical trials. Stem Cells Translational Medicine, 12(8), 510\u2013526.","journal-title":"Stem Cells Translational Medicine"},{"key":"5865_CR23","volume":"15","author":"L Wu","year":"2024","unstructured":"Wu, L., Lu, J., Lan, T., Zhang, D., Xu, H., Kang, Z., et al. (2024). Stem cell therapies: A new era in the treatment of multiple sclerosis. Frontiers in Neurology, 15, Article 1389697.","journal-title":"Frontiers in Neurology"},{"issue":"2","key":"5865_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jnc.12084","volume":"124","author":"GC Bellenchi","year":"2013","unstructured":"Bellenchi, G. C., Volpicelli, F., Piscopo, V., Perrone-Capano, C., & Di Porzio, U. (2013). Adult neural stem cells: An endogenous tool to repair brain injury? Journal of neurochemistry, 124(2), 159\u2013167.","journal-title":"Journal of neurochemistry"},{"issue":"5052","key":"5865_CR25","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.1553558","volume":"255","author":"BA Reynolds","year":"1992","unstructured":"Reynolds, B. A., & Weiss, S. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. science, 255(5052), 1707\u20131710.","journal-title":"science"},{"issue":"4","key":"5865_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm837","volume":"9","author":"MC Nunes","year":"2003","unstructured":"Nunes, M. C., Roy, N. S., Keyoung, H. M., Goodman, R. R., McKhann, G., Jiang, L., et al. (2003). Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nature medicine, 9(4), 439\u2013447.","journal-title":"Nature medicine"},{"issue":"12","key":"5865_CR27","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/cns.13497","volume":"26","author":"D Chen","year":"2020","unstructured":"Chen, D., Huang, Y., Shi, Z., Li, J., Zhang, Y., Wang, K., et al. (2020). Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy. CNS neuroscience & therapeutics, 26(12), 1219\u20131229.","journal-title":"CNS neuroscience & therapeutics"},{"issue":"3","key":"5865_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/00207454.2019.1677648","volume":"130","author":"TO Tobore","year":"2020","unstructured":"Tobore, T. O. (2020). Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis. International journal of neuroscience, 130(3), 279\u2013300.","journal-title":"International journal of neuroscience"},{"key":"5865_CR29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ane.12234","volume":"129","author":"C Jacobsen","year":"2014","unstructured":"Jacobsen, C., & Farbu, E. (2014). MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: An overview of current knowledge. Acta Neurologica Scandinavica, 129, 32\u201336.","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"5865_CR30","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02360-3","volume":"18","author":"MM Standiford","year":"2021","unstructured":"Standiford, M. M., Grund, E. M., & Howe, C. L. (2021). Citrullinated myelin induces microglial TNF\u03b1 and inhibits endogenous repair in the cuprizone model of demyelination. Journal of Neuroinflammation, 18(1), Article 305.","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"5865_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40893-016-0012-0","volume":"1","author":"F P\u00e9rez-Cerd\u00e1","year":"2016","unstructured":"P\u00e9rez-Cerd\u00e1, F., S\u00e1nchez-G\u00f3mez, M. V., & Matute, C. (2016). The link of inflammation and neurodegeneration in progressive multiple sclerosis. Multiple Sclerosis and Demyelinating Disorders, 1(1), 9.","journal-title":"Multiple Sclerosis and Demyelinating Disorders"},{"issue":"3","key":"5865_CR32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., S\u00f8rensen, P. S., Thompson, A. J., et al. (2014). Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology, 83(3), 278\u2013286.","journal-title":"Neurology"},{"issue":"8","key":"5865_CR33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","volume":"97","author":"BA Cree","year":"2021","unstructured":"Cree, B. A., Arnold, D. L., Chataway, J., Chitnis, T., Fox, R. J., Pozo Ramajo, A., et al. (2021). Secondary progressive multiple sclerosis: New insights. Neurology, 97(8), 378\u2013388.","journal-title":"Neurology"},{"issue":"1","key":"5865_CR34","volume":"15","author":"GM Mey","year":"2023","unstructured":"Mey, G. M., Mahajan, K. R., & DeSilva, T. M. (2023). Neurodegeneration in multiple sclerosis. WIREs Mechanisms of Disease, 15(1), Article e1583.","journal-title":"WIREs Mechanisms of Disease"},{"issue":"1","key":"5865_CR35","doi-asserted-by":"crossref","DOI":"10.3390\/books978-3-7258-2345-1","volume":"21","author":"P-F Wang","year":"2024","unstructured":"Wang, P.-F., Jiang, F., Zeng, Q.-M., Yin, W.-F., Hu, Y.-Z., Li, Q., et al. (2024). Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis. Journal of Neuroinflammation, 21(1), Article 28.","journal-title":"Journal of Neuroinflammation"},{"issue":"10127","key":"5865_CR36","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","volume":"391","author":"L Kappos","year":"2018","unstructured":"Kappos, L., Bar-Or, A., Cree, B. A., Fox, R. J., Giovannoni, G., Gold, R., et al. (2018). Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): A double-blind, randomised, phase 3 study. The Lancet, 391(10127), 1263\u20131273.","journal-title":"The Lancet"},{"issue":"3","key":"5865_CR37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., et al. (2017). Ocrelizumab versus placebo in primary progressive multiple sclerosis. New England Journal of Medicine, 376(3), 209\u201320.","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"5865_CR38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou, C. A., Fugger, L., & Friese, M. A. (2015). Immunopathology of multiple sclerosis. Nature Reviews Immunology, 15(9), 545\u2013558.","journal-title":"Nature Reviews Immunology"},{"issue":"5","key":"5865_CR39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/13543784.2020.1757647","volume":"29","author":"P Villoslada","year":"2020","unstructured":"Villoslada, P., & Steinman, L. (2020). New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis. Expert Opinion on Investigational Drugs, 29(5), 443\u2013459.","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"12","key":"5865_CR40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"RJ Franklin","year":"2017","unstructured":"Franklin, R. J., & Ffrench-Constant, C. (2017). Regenerating CNS myelin\u2014from mechanisms to experimental medicines. Nature Reviews Neuroscience, 18(12), 753\u2013769.","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"5865_CR41","doi-asserted-by":"crossref","first-page":"e1300037","DOI":"10.1080\/23262133.2017.1300037","volume":"4","author":"W Xu","year":"2017","unstructured":"Xu, W., Nishanth, L., & Morshead, C. M. (2017). Building a central nervous system: The neural stem cell lineage revealed. Neurogenesis, 4(1), e1300037.","journal-title":"Neurogenesis"},{"key":"5865_CR42","doi-asserted-by":"crossref","DOI":"10.1177\/1179069519856876","volume":"13","author":"HS Ghosh","year":"2019","unstructured":"Ghosh, H. S. (2019). Adult neurogenesis and the promise of adult neural stem cells. Journal of Experimental Neuroscience, 13, Article 1179069519856876.","journal-title":"Journal of Experimental Neuroscience"},{"key":"5865_CR43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11515-015-1364-0","volume":"10","author":"DA Berg","year":"2015","unstructured":"Berg, D. A., Yoon, K.-J., Will, B., Xiao, A. Y., Kim, N.-S., Christian, K. M., et al. (2015). Tbr2-expressing intermediate progenitor cells in the adult mouse hippocampus are unipotent neuronal precursors with limited amplification capacity under homeostasis. Frontiers in Biology, 10, 262\u201371.","journal-title":"Frontiers in Biology"},{"issue":"30","key":"5865_CR44","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1073\/pnas.1508545112","volume":"112","author":"GJ Sun","year":"2015","unstructured":"Sun, G. J., Zhou, Y., Stadel, R. P., Moss, J., Yong, J. H. A., Ito, S., et al. (2015). Tangential migration of neuronal precursors of glutamatergic neurons in the adult mammalian brain. Proceedings of the National Academy of Sciences of the United States of America, 112(30), 9484\u20139.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"5865_CR45","doi-asserted-by":"crossref","first-page":"E1045","DOI":"10.1073\/pnas.1219563110","volume":"110","author":"G Ponti","year":"2013","unstructured":"Ponti, G., Obernier, K., Guinto, C., Jose, L., Bonfanti, L., & Alvarez-Buylla, A. (2013). Cell cycle and lineage progression of neural progenitors in the ventricular-subventricular zones of adult mice. Proceedings of the National Academy of Sciences, 110(11), E1045\u2013E54.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"9","key":"5865_CR46","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s12264-024-01206-1","volume":"40","author":"H Meng","year":"2024","unstructured":"Meng, H., Huan, Y., Zhang, K., Yi, X., Meng, X., Kang, E., et al. (2024). Quiescent Adult Neural Stem Cells: Developmental Origin and Regulatory Mechanisms. Neuroscience Bulletin, 40(9), 1353\u20131363.","journal-title":"Neuroscience Bulletin"},{"issue":"7414","key":"5865_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nature11306","volume":"489","author":"J Song","year":"2012","unstructured":"Song, J., Zhong, C., Bonaguidi, M. A., Sun, G. J., Hsu, D., Gu, Y., et al. (2012). Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision. Nature, 489(7414), 150\u2013154.","journal-title":"Nature"},{"issue":"6","key":"5865_CR48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm3591","volume":"14","author":"TH Cheung","year":"2013","unstructured":"Cheung, T. H., & Rando, T. A. (2013). Molecular regulation of stem cell quiescence. Nature reviews Molecular cell biology, 14(6), 329\u2013340.","journal-title":"Nature reviews Molecular cell biology"},{"issue":"3","key":"5865_CR49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.stem.2015.07.013","volume":"17","author":"J Shin","year":"2015","unstructured":"Shin, J., Berg, D. A., Zhu, Y., Shin, J. Y., Song, J., Bonaguidi, M. A., et al. (2015). Single-cell RNA-seq with waterfall reveals molecular cascades underlying adult neurogenesis. Cell Stem Cell, 17(3), 360\u201372.","journal-title":"Cell Stem Cell"},{"key":"5865_CR50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clineuro.2018.07.013","volume":"173","author":"C Grochowski","year":"2018","unstructured":"Grochowski, C., Radzikowska, E., & Maciejewski, R. (2018). Neural stem cell therapy\u2014Brief review. Clinical neurology and neurosurgery, 173, 8\u201314.","journal-title":"Clinical neurology and neurosurgery"},{"issue":"9","key":"5865_CR51","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092377","volume":"10","author":"B Fernandez-Mu\u00f1oz","year":"2021","unstructured":"Fernandez-Mu\u00f1oz, B., Garcia-Delgado, A. B., Arribas-Arribas, B., & Sanchez-Pernaute, R. (2021). Human neural stem cells for cell-based medicinal products. Cells, 10(9), Article 2377.","journal-title":"Cells"},{"issue":"7","key":"5865_CR52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006286","volume":"4","author":"E Abranches","year":"2009","unstructured":"Abranches, E., Silva, M., Pradier, L., Schulz, H., Hummel, O., Henrique, D., et al. (2009). Neural differentiation of embryonic stem cells in vitro: A road map to neurogenesis in the embryo. PLoS One, 4(7), Article e6286.","journal-title":"PLoS One"},{"issue":"18","key":"5865_CR53","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1089\/scd.2012.0520","volume":"22","author":"WF Alsanie","year":"2013","unstructured":"Alsanie, W. F., Niclis, J. C., & Petratos, S. (2013). Human Embryonic Stem Cell-Derived Oligodendrocytes: Protocols and Perspectives. Stem Cells and Development, 22(18), 2459\u20132476.","journal-title":"Stem Cells and Development"},{"issue":"1","key":"5865_CR54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13041-016-0265-8","volume":"9","author":"K Sugai","year":"2016","unstructured":"Sugai, K., Fukuzawa, R., Shofuda, T., Fukusumi, H., Kawabata, S., Nishiyama, Y., et al. (2016). Pathological classification of human iPSC-derived neural stem\/progenitor cells towards safety assessment of transplantation therapy for CNS diseases. Molecular Brain, 9(1), 85.","journal-title":"Molecular Brain"},{"issue":"1","key":"5865_CR55","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02563-8","volume":"12","author":"C Brown","year":"2021","unstructured":"Brown, C., McKee, C., Halassy, S., Kojan, S., Feinstein, D. L., & Chaudhry, G. R. (2021). Neural stem cells derived from primitive mesenchymal stem cells reversed disease symptoms and promoted neurogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Stem Cell Research & Therapy, 12(1), Article 499.","journal-title":"Stem Cell Research & Therapy"},{"issue":"49","key":"5865_CR56","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc6983","volume":"6","author":"S Mozafari","year":"2020","unstructured":"Mozafari, S., Starost, L., Manot-Saillet, B., Garcia-Diaz, B., Xu, Y. K. T., Roussel, D., et al. (2020). Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo. Science Advances, 6(49), Article eabc6983.","journal-title":"Science Advances"},{"issue":"5858","key":"5865_CR57","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., et al. (2007). Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science, 318(5858), 1917\u20131920.","journal-title":"Science"},{"issue":"2","key":"5865_CR58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5966\/sctm.2015-0414","volume":"6","author":"V Meneghini","year":"2016","unstructured":"Meneghini, V., Frati, G., Sala, D., De Cicco, S., Luciani, M., Cavazzin, C., et al. (2016). Generation of human induced pluripotent stem cell-derived bona fide neural stem cells for ex vivo gene therapy of metachromatic leukodystrophy. Stem Cells Translational Medicine, 6(2), 352\u201368.","journal-title":"Stem Cells Translational Medicine"},{"issue":"3","key":"5865_CR59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/scrt224","volume":"4","author":"T Yuan","year":"2013","unstructured":"Yuan, T., Liao, W., Feng, N-H., Lou, Y-L., Niu, X., Zhang, A-J., et al. (2013). Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion. Stem Cell Research & Therapy, 4(3), 73.","journal-title":"Stem Cell Research & Therapy"},{"issue":"11","key":"5865_CR60","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.18103\/mra.v11i11.4784","volume":"11","author":"AB Moy","year":"2023","unstructured":"Moy, A. B., Kamath, A., Ternes, S., & Kamath, J. (2023). The challenges to advancing induced pluripotent stem cell-dependent cell replacement therapy. Medical Research Archives, 11(11):4784. https:\/\/doi.org\/10.18103\/mra.v11i11.4784","journal-title":"Medical Research Archives"},{"issue":"4","key":"5865_CR61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1474-4422(06)70410-0","volume":"5","author":"M Rovaris","year":"2006","unstructured":"Rovaris, M., Confavreux, C., Furlan, R., Kappos, L., Comi, G., & Filippi, M. (2006). Secondary progressive multiple sclerosis: Current knowledge and future challenges. The Lancet Neurology, 5(4), 343\u2013354.","journal-title":"The Lancet Neurology"},{"key":"5865_CR62","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-0953-0","volume":"123","author":"J Antel","year":"2012","unstructured":"Antel, J., Antel, S., Caramanos, Z., Arnold, D. L., & Kuhlmann, T. (2012). Primary progressive multiple sclerosis: Part of the MS disease spectrum or separate disease entity? Acta neuropathologica, 123, 627\u2013638.","journal-title":"Acta neuropathologica"},{"key":"5865_CR63","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1007\/s12035-017-0566-7","volume":"55","author":"J Xiao","year":"2018","unstructured":"Xiao, J., Yang, R., Biswas, S., Zhu, Y., Qin, X., Zhang, M., et al. (2018). Neural stem cell-based regenerative approaches for the treatment of multiple sclerosis. Molecular neurobiology, 55, 3152\u20133171.","journal-title":"Molecular neurobiology"},{"issue":"6933","key":"5865_CR64","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nature01552","volume":"422","author":"S Pluchino","year":"2003","unstructured":"Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., et al. (2003). Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature, 422(6933), 688\u201394.","journal-title":"Nature"},{"issue":"8","key":"5865_CR65","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3390\/cells10082045","volume":"10","author":"Z Finkel","year":"2021","unstructured":"Finkel, Z., Esteban, F., Rodriguez, B., Fu, T., Ai, X., & Cai, L. (2021). Diversity of adult neural stem and progenitor cells in physiology and disease. Cells, 10(8), 2045.","journal-title":"Cells"},{"issue":"2","key":"5865_CR66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cbin.11500","volume":"45","author":"J Langhnoja","year":"2021","unstructured":"Langhnoja, J., Buch, L., & Pillai, P. (2021). Potential role of NGF, BDNF, and their receptors in oligodendrocytes differentiation from neural stem cell: An in vitro study. Cell Biology International, 45(2), 432\u2013446.","journal-title":"Cell Biology International"},{"issue":"1","key":"5865_CR67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1073858415616559","volume":"23","author":"R Covacu","year":"2017","unstructured":"Covacu, R., & Brundin, L. (2017). Effects of Neuroinflammation on Neural Stem Cells. The Neuroscientist, 23(1), 27\u201339.","journal-title":"The Neuroscientist"},{"key":"5865_CR68","first-page":"45","volume":"2","author":"F Tahmasebi","year":"2025","unstructured":"Tahmasebi, F., Asl, E. R., Faghihi, F., Bolandi, N., & Barati, S. (2025). Synergistic effects of olfactory ecto-mesenchymal stem cell supernatant and ellagic acid on demyelination and glial modulation in a chronic multiple sclerosis model. Cellular and Molecular Neurobiology, 2, 45\u201340.","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"1","key":"5865_CR69","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1186\/1742-2094-10-106","volume":"10","author":"R Zhang","year":"2013","unstructured":"Zhang, R., Liu, Y., Yan, K., Chen, L., Chen, X-R., Li, P., et al. (2013). Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. Journal of Neuroinflammation, 10(1), 871.","journal-title":"Journal of Neuroinflammation"},{"key":"5865_CR70","volume":"370","author":"C Gu","year":"2023","unstructured":"Gu, C., Li, Y., Liu, J., Liu, S., Long, J., Zhang, Q., et al. (2023). Neural stem cell-derived exosomes-loaded adhesive hydrogel controlled-release promotes cerebral angiogenesis and neurological function in ischemic stroke. Experimental Neurology, 370, Article 114547.","journal-title":"Experimental Neurology"},{"issue":"3","key":"5865_CR71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4103\/1673-5374.380874","volume":"19","author":"J Chang","year":"2024","unstructured":"Chang, J., Li, Y., Shan, X., Chen, X., Yan, X., Liu, J., et al. (2024). Neural stem cells promote neuroplasticity: A promising therapeutic strategy for the treatment of Alzheimer\u2019s disease. Neural Regeneration Research, 19(3), 619\u201328.","journal-title":"Neural Regeneration Research"},{"issue":"2","key":"5865_CR72","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1471-4159.2006.04394.x","volume":"101","author":"C Weidenfeller","year":"2007","unstructured":"Weidenfeller, C., Svendsen, C. N., & Shusta, E. V. (2007). Differentiating embryonic neural progenitor cells induce blood\u2013brain barrier properties. Journal of neurochemistry, 101(2), 555\u2013565.","journal-title":"Journal of neurochemistry"},{"issue":"9","key":"5865_CR73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093103","volume":"21","author":"R De Gioia","year":"2020","unstructured":"De Gioia, R., Biella, F., Citterio, G., Rizzo, F., Abati, E., Nizzardo, M., et al. (2020). Neural stem cell transplantation for neurodegenerative diseases. International Journal of Molecular Sciences, 21(9), Article 3103.","journal-title":"International Journal of Molecular Sciences"},{"key":"5865_CR74","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","volume":"759","author":"C Procaccini","year":"2015","unstructured":"Procaccini, C., De Rosa, V., Pucino, V., Formisano, L., & Matarese, G. (2015). Animal models of multiple sclerosis. European Journal of Pharmacology, 759, 182\u201391.","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"5865_CR75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bpa.12454","volume":"27","author":"M Kipp","year":"2017","unstructured":"Kipp, M., Nyamoya, S., Hochstrasser, T., & Amor, S. (2017). Multiple sclerosis animal models: A clinical and histopathological perspective. Brain pathology, 27(2), 123\u2013137.","journal-title":"Brain pathology"},{"issue":"15","key":"5865_CR76","doi-asserted-by":"publisher","first-page":"1415365","DOI":"10.3389\/fmicb.2024.1415365","volume":"26","author":"L Li","year":"2024","unstructured":"Li, L., Zhou, R., & Sun, L. (2024). Application of Theiler\u2019s murine encephalomyelitis virus in treatment of multiple sclerosis. Frontiers in Microbiology, 26(15),1415365. https:\/\/doi.org\/10.3389\/fmicb.2024.1415365","journal-title":"Frontiers in Microbiology"},{"key":"5865_CR77","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/B978-0-12-809468-6.00037-1","volume-title":"Animal Models for the Study of Human Disease (Second Edition)","author":"RH Miller","year":"2017","unstructured":"Miller, R. H., Fyffe-Maricich, S., & Caprariello, A. C. (2017). Chapter 37 - Animal Models for the Study of Multiple Sclerosis. In P. M. Conn (Ed.), Animal Models for the Study of Human Disease (Second Edition) (pp. 967\u201388). Academic Press."},{"issue":"3","key":"5865_CR78","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1352458518805246","volume":"25","author":"DJ Burrows","year":"2019","unstructured":"Burrows, D. J., McGown, A., Jain, S. A., De Felice, M., Ramesh, T. M., Sharrack, B., et al. (2019). Animal models of multiple sclerosis: From rodents to zebrafish. Multiple Sclerosis Journal, 25(3), 306\u201324.","journal-title":"Multiple Sclerosis Journal"},{"issue":"2","key":"5865_CR79","first-page":"95","volume":"2","author":"JP Holloman","year":"2013","unstructured":"Holloman, J. P., Ho, C. C., Hukki, A., Huntley, J. L., & Gallicano, G. I. (2013). The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis. Am J Stem Cells, 2(2), 95\u2013107.","journal-title":"Am J Stem Cells"},{"issue":"12","key":"5865_CR80","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","volume":"24","author":"AM Falc\u00e3o","year":"2018","unstructured":"Falc\u00e3o, A. M., van Bruggen, D., Marques, S., Meijer, M., J\u00e4kel, S., Agirre, E., et al. (2018). Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nature Medicine, 24(12), 1837\u20131844.","journal-title":"Nature Medicine"},{"issue":"6","key":"5865_CR81","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/mrm.22757","volume":"65","author":"N Muja","year":"2011","unstructured":"Muja, N., Cohen, M. E., Zhang, J., Kim, H., Gilad, A. A., Walczak, P., et al. (2011). Neural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: A serial MR imaging study. Magnetic Resonance In Medicine, 65(6), 1738\u20131749.","journal-title":"Magnetic Resonance In Medicine"},{"key":"5865_CR82","doi-asserted-by":"crossref","first-page":"1413843","DOI":"10.3389\/fncel.2024.1413843","volume":"18","author":"SIP Santos","year":"2024","unstructured":"Santos, S. I. P., Ortiz-Pe\u00f1uela, S. J., de Paula Filho, A., Tomiyama, A., Coser, L. O., da Silveira, J. C., et al. (2024). Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation. Frontiers In Cellular Neuroscience, 18, 1413843.","journal-title":"Frontiers In Cellular Neuroscience"},{"issue":"3","key":"5865_CR83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/rme-2023-0005","volume":"18","author":"VK Harris","year":"2023","unstructured":"Harris, V. K., Bishop, D., Wollowitz, J., Carling, G., Carlson, A. L., Daviaud, N., et al. (2023). Mesenchymal stem cell-derived neural progenitors attenuate proinflammatory microglial activation via paracrine mechanisms. Regenerative Medicine, 18(3), 259\u201373.","journal-title":"Regenerative Medicine"},{"issue":"4","key":"5865_CR84","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13040","volume":"32","author":"P Theotokis","year":"2022","unstructured":"Theotokis, P., Kesidou, E., Mitsiadou, D., Petratos, S., Damianidou, O., Boziki, M., et al. (2022). Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination. Brain Pathology, 32(4), Article e13040.","journal-title":"Brain Pathology"},{"key":"5865_CR85","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2019.05.009","volume":"212","author":"M Ben-Zwi","year":"2019","unstructured":"Ben-Zwi, M., Petrou, P., Halimi, M., Karussis, D., & Kassis, I. (2019). Neuralized mesenchymal stem cells (NMSC) exhibit phenotypical, and biological evidence of neuronal transdifferentiation and suppress EAE more effectively than unmodified MSC. Immunology Letters, 212, 6\u201313.","journal-title":"Immunology Letters"},{"issue":"2","key":"5865_CR86","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12035-019-01802-7","volume":"57","author":"Y Nishri","year":"2020","unstructured":"Nishri, Y., Hampton, D., Ben-Shushan, E., Fainstein, N., Magnani, D., Aharonowiz, M., et al. (2020). Continuous Immune-Modulatory Effects of Human Olig2\u2009+\u2009Precursor Cells Attenuating a Chronic-Active Model of Multiple Sclerosis. Molecular Neurobiology, 57(2), 1021\u20131034.","journal-title":"Molecular Neurobiology"},{"issue":"9","key":"5865_CR87","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/cells8091025","volume":"8","author":"Y Maeda","year":"2019","unstructured":"Maeda, Y., Nakagomi, N., Nakano-Doi, A., Ishikawa, H., Tatsumi, Y., Bando, Y., et al. (2019). Potential of adult endogenous neural stem\/progenitor cells in the spinal cord to contribute to remyelination in experimental autoimmune encephalomyelitis. Cells, 8(9),1025. https:\/\/doi.org\/10.3390\/cells8091025","journal-title":"Cells"},{"issue":"1","key":"5865_CR88","doi-asserted-by":"crossref","first-page":"68","DOI":"10.15283\/ijsc17052","volume":"11","author":"F Nasri","year":"2018","unstructured":"Nasri, F., Mohtasebi, M. S., Hashemi, E., Zarrabi, M., Gholijani, N., & Sarvestani, E. K. (2018). Therapeutic efficacy of mesenchymal stem cells and mesenchymal stem cells-derived neural progenitors in experimental autoimmune encephalomyelitis. International Journal of Stem Cells, 11(1), 68\u201377.","journal-title":"International Journal of Stem Cells"},{"issue":"9","key":"5865_CR89","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s11427-016-0114-9","volume":"59","author":"C Zhang","year":"2016","unstructured":"Zhang, C., Cao, J., Li, X., Xu, H., Wang, W., Wang, L., et al. (2016). Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells. Science China, Life Sciences, 59(9), 950\u20137.","journal-title":"Science China, Life Sciences"},{"issue":"12","key":"5865_CR90","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.5966\/sctm.2015-0068","volume":"4","author":"S Ravanidis","year":"2015","unstructured":"Ravanidis, S., Poulatsidou, K. N., Lagoudaki, R., Touloumi, O., Polyzoidou, E., Lourbopoulos, A., et al. (2015). Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System. Stem Cells Transl Med, 4(12), 1450\u20131462.","journal-title":"Stem Cells Transl Med"},{"key":"5865_CR91","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1038\/ncomms3597","volume":"4","author":"C Laterza","year":"2013","unstructured":"Laterza, C., Merlini, A., De Feo, D., Ruffini, F., Menon, R., Onorati, M., et al. (2013). iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF. Nature Communications, 4, 2597.","journal-title":"Nature Communications"},{"issue":"6","key":"5865_CR92","first-page":"596","volume":"14","author":"H Rafieemehr","year":"2015","unstructured":"Rafieemehr, H., Kheyrandish, M., & Soleimani, M. (2015). Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE. Iranian Journal Of Allergy, Asthma, And Immunology, 14(6), 596\u2013604.","journal-title":"Iranian Journal Of Allergy, Asthma, And Immunology"},{"key":"5865_CR93","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1742-2094-10-117","volume":"10","author":"J Klose","year":"2013","unstructured":"Klose, J., Schmidt, N. O., Melms, A., Dohi, M., Miyazaki, J., Bischof, F., et al. (2013). Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem\/progenitor cells. J Neuroinflammation, 10, 117.","journal-title":"J Neuroinflammation"},{"issue":"1\u20132","key":"5865_CR94","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2011.08.036","volume":"313","author":"VK Harris","year":"2012","unstructured":"Harris, V. K., Yan, Q. J., Vyshkina, T., Sahabi, S., Liu, X., & Sadiq, S. A. (2012). Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis. Journal of the Neurological Sciences, 313(1\u20132), 167\u201377.","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"5865_CR95","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3727\/096368910X543411","volume":"20","author":"KP Reekmans","year":"2011","unstructured":"Reekmans, K. P., Praet, J., De Vocht, N., Tambuyzer, B. R., Bergwerf, I., Daans, J., et al. (2011). Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice? Cell Transplantation, 20(6), 851\u201369.","journal-title":"Cell Transplantation"},{"issue":"9","key":"5865_CR96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003145","volume":"3","author":"M Aharonowiz","year":"2008","unstructured":"Aharonowiz, M., Einstein, O., Fainstein, N., Lassmann, H., Reubinoff, B., & Ben-Hur, T. (2008). Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One, 3(9), Article e3145.","journal-title":"PLoS One"},{"issue":"6","key":"5865_CR97","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1007\/s12035-016-9994-z","volume":"54","author":"X Li","year":"2017","unstructured":"Li, X., Zhang, Y., Yan, Y., Ciric, B., Ma, C. G., Chin, J., et al. (2017). LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis. Molecular Neurobiology, 54(6), 4365\u20134378.","journal-title":"Molecular Neurobiology"},{"issue":"8","key":"5865_CR98","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s12015-024-10791-7","volume":"20","author":"M Rahnama","year":"2024","unstructured":"Rahnama, M., Heidari, M., Poursalehi, Z., & Golchin, A. (2024). Global trends of exosomes application in clinical trials: A scoping review. Stem Cell Reviews and Reports, 20(8), 2165\u201393.","journal-title":"Stem Cell Reviews and Reports"},{"issue":"12","key":"5865_CR99","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jcyt.2016.08.007","volume":"18","author":"VK Harris","year":"2016","unstructured":"Harris, V. K., Vyshkina, T., & Sadiq, S. A. (2016). Clinical safety of intrathecal administration of mesenchymal stromal cell\u2013derived neural progenitors in multiple sclerosis. Cytotherapy, 18(12), 1476\u20131482.","journal-title":"Cytotherapy"},{"key":"5865_CR100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ebiom.2018.02.002","volume":"29","author":"VK Harris","year":"2018","unstructured":"Harris, V. K., Stark, J., Vyshkina, T., Blackshear, L., Joo, G., Stefanova, V., et al. (2018). Phase I trial of intrathecal mesenchymal stem cell-derived neural progenitors in progressive multiple sclerosis. EBioMedicine, 29, 23\u201330.","journal-title":"EBioMedicine"},{"issue":"1","key":"5865_CR101","doi-asserted-by":"publisher","first-page":"e928","DOI":"10.1212\/NXI.0000000000000928","volume":"8","author":"VK Harris","year":"2021","unstructured":"Harris, V. K., Stark, J. W., Yang, S., Zanker, S., Tuddenham, J., & Sadiq, S. A. (2021). Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study. Neurology(R) Neuroimmunology & Neuroinflammation, 8(1),e928. https:\/\/doi.org\/10.1212\/NXI.0000000000000928","journal-title":"Neurology(R) Neuroimmunology & Neuroinflammation"},{"issue":"1","key":"5865_CR102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13287-024-03765-6","volume":"15","author":"VK Harris","year":"2024","unstructured":"Harris, V. K., Stark, J., Williams, A., Roche, M., Malin, M., Kumar, A., et al. (2024). Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: Results from a phase II, randomized, placebo-controlled clinical trial. Stem Cell Research & Therapy, 15(1), 151.","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"5865_CR103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41591-022-02097-3","volume":"29","author":"A Genchi","year":"2023","unstructured":"Genchi, A., Brambilla, E., Sangalli, F., Radaelli, M., Bacigaluppi, M., Furlan, R., et al. (2023). Neural stem cell transplantation in patients with progressive multiple sclerosis: An open-label, phase 1 study. Nature Medicine, 29(1), 75\u201385.","journal-title":"Nature Medicine"},{"issue":"12","key":"5865_CR104","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.stem.2023.11.001","volume":"30","author":"MA Leone","year":"2023","unstructured":"Leone, M. A., Gelati, M., Profico, D. C., Gobbi, C., Pravat\u00e0, E., Copetti, M., et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell, 30(12), 1597\u2013609e8.","journal-title":"Cell Stem Cell"},{"key":"5865_CR105","doi-asserted-by":"crossref","first-page":"1248271","DOI":"10.3389\/fnmol.2023.1248271","volume":"16","author":"EA Salegio","year":"2023","unstructured":"Salegio, E. A., Hancock, K., & Korszen, S. (2023). Pre-clinical delivery of gene therapy products to the cerebrospinal fluid: challenges and considerations for clinical translation. Frontiers in Molecular Neuroscience, 16, 1248271.","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"10","key":"5865_CR106","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.molmed.2020.04.005","volume":"26","author":"S Pluchino","year":"2020","unstructured":"Pluchino, S., Smith, J. A., & Peruzzotti-Jametti, L. (2020). Promises and limitations of neural stem cell therapies for progressive multiple sclerosis. Trends in Molecular Medicine, 26(10), 898\u2013912.","journal-title":"Trends in Molecular Medicine"},{"issue":"5","key":"5865_CR107","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2522\/ptj.20150063","volume":"96","author":"HH Ross","year":"2016","unstructured":"Ross, H. H., Ambrosio, F., Trumbower, R. D., Reier, P. J., Behrman, A. L., & Wolf, S. L. (2016). Neural stem cell therapy and rehabilitation in the central nervous system: Emerging partnerships. Physical Therapy, 96(5), 734\u2013742.","journal-title":"Physical Therapy"},{"issue":"11","key":"5865_CR108","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcyt.2024.05.022","volume":"26","author":"M Madrid","year":"2024","unstructured":"Madrid, M., Lakshmipathy, U., Zhang, X., Bharti, K., Wall, D. M., Sato, Y., et al. (2024). Considerations for the development of iPSC-derived cell therapies: A review of key challenges by the JSRM-ISCT iPSC Committee. Cytotherapy, 26(11), 1382\u20131399.","journal-title":"Cytotherapy"},{"key":"5865_CR109","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3606765","author":"A Revete","year":"2022","unstructured":"Revete, A., Aparicio, A., Cisterna, B. A., Revete, J., Luis, L., Ibarra, E., et al. (2022). Advancements in the use of hydrogels for regenerative medicine: Properties and biomedical applications. International Journal of Biomaterials. https:\/\/doi.org\/10.1155\/2022\/3606765","journal-title":"International Journal of Biomaterials"},{"issue":"8","key":"5865_CR110","volume":"26","author":"Y-P Yang","year":"2025","unstructured":"Yang, Y.-P., Nicol, C. J. B., & Chiang, M.-C. (2025). A review of the neuroprotective properties of exosomes derived from stem cells and exosome-coated nanoparticles for treating neurodegenerative diseases and stroke. International Journal of Molecular Sciences, 26(8), Article 3915.","journal-title":"International Journal of Molecular Sciences"},{"key":"5865_CR111","doi-asserted-by":"crossref","first-page":"1329712","DOI":"10.3389\/fbioe.2024.1329712","volume":"12","author":"L Yang","year":"2024","unstructured":"Yang, L., Liu, S-C., Liu, Y-Y., Zhu, F-Q., Xiong, M-J., & Hu, D-X. (2024). Therapeutic role of neural stem cells in neurological diseases. Frontiers in Bioengineering and Biotechnology, 12, 1329712.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"12","key":"5865_CR112","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3727\/096368914X679354","volume":"24","author":"S Rosenblum","year":"2015","unstructured":"Rosenblum, S., Smith, T. N., Wang, N., Chua, J. Y., Westbroek, E., Wang, K., et al. (2015). BDNF Pretreatment of Human Embryonic-Derived Neural Stem Cells Improves Cell Survival and Functional Recovery after Transplantation in Hypoxic\u2013Ischemic Stroke. Cell Transplantation, 24(12), 2449\u20132461.","journal-title":"Cell Transplantation"},{"issue":"4, Part 2","key":"5865_CR113","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.lpm.2015.02.011","volume":"44","author":"B Bodini","year":"2015","unstructured":"Bodini, B., Louapre, C., & Stankoff, B. (2015). Advanced imaging tools to investigate multiple sclerosis pathology. La Presse M\u00e9dicale, 44(4, Part 2), e159\u2013e67.","journal-title":"La Presse M\u00e9dicale"},{"key":"5865_CR114","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/7651_2013_27","volume-title":"Imaging and Tracking Stem Cells: Methods and Protocols","author":"T Spiriev","year":"2013","unstructured":"Spiriev, T., Sandu, N., & Schaller, B. (2013). Molecular Imaging and Tracking Stem Cells in Neurosciences. In K. Turksen (Ed.), Imaging and Tracking Stem Cells: Methods and Protocols (pp. 195\u2013201). Humana Press."},{"issue":"6","key":"5865_CR115","first-page":"484959","volume":"35","author":"A Gajofatto","year":"2013","unstructured":"Gajofatto, A., Calabrese, M., Benedetti, M. D., & Monaco, S. (2013). Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis. Disease Markers, 35(6), 484959.","journal-title":"Disease Markers"},{"key":"5865_CR116","volume":"15","author":"L Wu","year":"2024","unstructured":"Wu, L., Lu, J., Lan, T., Zhang, D., Xu, H., Kang, Z., et al. (2024). Stem cell therapies: A new era in the treatment of multiple sclerosis. Frontiers in Neurology, 15, Article 2024.","journal-title":"Frontiers in Neurology"},{"key":"5865_CR117","doi-asserted-by":"publisher","first-page":"e18743722461284","DOI":"10.2174\/0118743722461284260209104738","volume":"20","author":"A Golchin","year":"2026","unstructured":"Golchin, A., Sadigh, S., Jafari, S., Ranjbari, H., Rahnama, M., Ghasemzadeh, N., et al. (2026). Nanobiomaterials for skin tissue engineering and regenerative medicine: From mechanistic understanding to clinical translation. The Open Dermatology Journal, 20, e18743722461284. https:\/\/doi.org\/10.2174\/0118743722461284260209104738","journal-title":"The Open Dermatology Journal"},{"issue":"1","key":"5865_CR118","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12015-025-11007-2","volume":"22","author":"M Rahnama","year":"2026","unstructured":"Rahnama, M., Abbasi, F., Ranjbarvan, P., & Golchin, A. (2026). The potential of menstrual blood-derived extracellular vesicles (MenMSC-Evs) in combination with platelet-rich fibrin (PRF) as a biological adjuvant for improving full-thickness wound healing. Stem Cell Reviews and Reports, 22(1), 599\u2013619.","journal-title":"Stem Cell Reviews and Reports"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05865-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05865-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05865-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:17:07Z","timestamp":1792077427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05865-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":118,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5865"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05865-w","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"29 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The project was approved by the Ethics Committee of Urmia University of Medical Sciences (IR.UMSU.REC.1404.204).","order":1,"name":"Ethics","label":"Human Ethics, Animal Ethics, and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no interest in the items or companies described in this article.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}